For more on AHA statements and guide- lines development, visit https://professional.heart.org/statements. Select the Guidelines & Statements drop-down menu near the top of the web page, then click Publication Development. Permissions: Multiple copies, modification, alteration, enhancement, and/ or distribution of this document are not permitted without the express permis- sion of the American Heart Association. Instructions for obtaining permission are are located at https://www.heart.org/permissions. A link to the Copyright Permissions Request Form appears in the second paragraph (https://www. heart.org/en/about-us/statements-and-policies/copyright-request-form). REFERENCES S1-1. Weir HK, Anderson RN, Coleman King SM, et al. Heart disease and can- cer deaths trends and projections in the United States, 1969 2020. Prev Chronic Dis. 2016;13:E157. S1-2. Johnson NB, Hayes LD, Brown K, et al. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors United States, 2005 2013. MMWR Suppl. 2014;63:3 27. S1-3. Xu J, Murphy SL, Kochanek KD, et al. Mortality in the United States, 2015. NCHS Data Brief. 2016:1 8. S1-4. Greenland P, Knoll MD, Stamler J, et al. Major risk factors as ante- cedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290:891 7. S1-5. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduc- tion: the American Heart Association s Strategic Impact Goal through 2020 and beyond. Circulation. 2010;121:586 613. S1-6. Turco JV, Inal-Veith A, Fuster V. Cardiovascular health promotion: an issue that can no longer wait. J Am Coll Cardiol. 2018;72:908 13. S1-7. Younus A, Aneni EC, Spatz ES, et al. A systematic review of the preva- lence and outcomes of ideal cardiovascular health in US and non-US populations. Mayo Clin Proc. 2016;91:649 70. 1.1. Methodology and Evidence Review S1.1-1. Whelton PK, Carey RM, Aronow WS, et al. 